Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 426-040-2 | CAS number: 25713-60-4 SR-245
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and appropriate guidelines
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: method B14 of the commission directive 92/69/EEC (annex V of council directive 67/548/EEC)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- not relevant
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine
- EC Number:
- 426-040-2
- EC Name:
- 2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5-triazine
- Cas Number:
- 25713-60-4
- Molecular formula:
- C 21 H 6 Br 9 N 3 O 3
- IUPAC Name:
- tris(2,4,6-tribromophenoxy)-1,3,5-triazine
- Reference substance name:
- 4260402
- IUPAC Name:
- 4260402
- Details on test material:
- Identification SR-245
Description White Powder
Batch 969066
Purity 100%
Test substance storage At room temperature in the dark
Stability under storage conditions Stable
Constituent 1
Constituent 2
Method
- Target gene:
- Histidine
Species / strain
- Species / strain / cell type:
- bacteria, other: Salmonella typhimurium TA1535, TA1537, TA98, TA100
- Details on mammalian cell type (if applicable):
- not relevant
- Additional strain / cell type characteristics:
- other: Strains TA98 and TA1537 were capable of detecting frameshift mutagens, strains TA100 and TA1535 are capable of detecting base-pair substitution mutagens
- Metabolic activation system:
- Aroclor-induced rat liver S9.
- Test concentrations with justification for top dose:
- Concentration range in the dose range finding test (with metabolic activation): 3, 10, 33, 100, 333, 1000, 3300, 5000 µg/plate
Concentration range in the dose range finding test (without metabolic activation): 3, 10, 33, 100, 333, 1000, 3300, 5000 µg/plate
Concentration range in the main test (without metabolic activation): 10, 33, 100, 333, 1000 µg/plate
Concentration range in the main test (without metabolic activation): 10, 33, 100, 333, 1000 µg/plate - Vehicle / solvent:
- Solvent: Dimethylsulphoxide
- Details on test system and experimental conditions:
- See attached document of test system
- Evaluation criteria:
- Test substance is considered negative (not mutagenic) in the test if:
1. The total number of revertants in any tester strain at any concentration is not greater than two times the solvent control value, with or without metabolic activation.
2. The negative response should be reproducible in at least one independently repeated experiment.
Test substance is considered positive (mutagenic) in the test if:
1. It induces at least a 2-fold, dose related increase in the number of revertants with respect to the number induced by the solvent control in any of the tester strains, either with or without metabolic activation. However, any mean plate count of less than 20 is considered to be not significant.
2. The positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision. - Statistics:
- See evaluation criteria
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- (> 5000 µg/plate)
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- (> 5000 µg/plate)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- (> 1000 µg/plate)
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- (> 1000 µg/plate)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- see attached document on results
- Remarks on result:
- other: other: dose range finding test
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
See attached file on tables and figures
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation SR-245 did not induce a dose related increase in the number of revertant colonies in the presence of S9-mix
negative without metabolic activation SR-245 did not induce a dose related increase in the number of revertant colonies in the absence of S9-mix
Based on the results of the study it is concluded that SR-245 is not mutagenic in the Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
